EPSRC IRC Submission of Evidence to the Select Committee Inquiry into AMR
[normal]&#xa0;
[normal]EPSRC IRC Submission of Evidence to the House of Commons Science &amp; Technology [bold]Select Committee Inquiry into Antimicrobial Resistance [bold]6
[normal]th
[normal] November 2013.
[normal]&#xa0;[bold]1.0 [bold]Executive [bold]Summary[bold] 
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]2.0 [bold]Who we are:[bold] [bold]We are a new EPSRC Interdisciplinary Research Collaboration
[normal] 
[normal](IRC) 
[normal]which aims to develop an Early Warning Sensing System for Infectious Diseases. 
[normal]The IRC brings together 
[normal]multidisciplinary teams of 
[normal]scientists, engineers and clinicians from UCL, Imperial College, the London School of Hygiene and Tropical Medicine, Newcastle University and Surrey University, together with NHS stakeholders
[normal],
[normal] UCL Partners, Public Health England and industry partners.
[normal] [bold]We are pleased to m
[normal]ake a short submission 
[normal]to the Select Committ
[normal]ee’s inquiry into AMR
[normal]1
[normal] 
[normal]and focus on the Committee’s questions regarding gaps in 
[normal]our 
[normal]knowledge 
[normal]of AMR 
[normal]and 
[normal]recommend 
[normal]prioritizing
[normal] fut
[normal]ure
[normal] research
[normal] in next generation diagnostics and surveillance
[normal].
[normal]&#xa0;
[normal]3.0[bold]&#xa0;&#xa0; 
[normal]How has AMR developed in the past decade?[bold]&#xa0;
[normal]3.1[bold]&#xa0;&#xa0; 
[normal]A key factor driving the development of AMR is 
[normal]the lack of rapid diagnostic and 
[normal]disease 
[normal]surveillance technologies 
[normal]to 
[normal]detect early-stage infections in community settings.
[normal]1
[normal]-6
[normal] 
[normal]The
[normal] result is that
[normal] worldwide many infections remain undiagnosed or are diagnosed at a late stage. This leads to on-going transmission 
[normal]by 
[normal]people
[normal] unaware of their infections
[normal] and
[normal] widespread inappropriate use of antibiotics which fuels drug-
[normal]resistance. Late diagnosis
[normal] also 
[normal]limits
[normal] 
[normal]our ability to 
[normal]respond to
[normal] 
[normal]emerging 
[normal]AMR strains
[normal].
[normal]&#xa0;
[normal]3.2[bold]&#xa0;&#xa0; 
[normal]Early detection plays a crucial role in all treatment and prevention strategies. 
[normal]H
[normal]owever,
[normal] current gold-standard diagnostic tests 
[normal](
[normal]e.g. 
[normal]RT-PCR and bacterial culture) are slow and 
[normal]require samples to be sent to specialist laboratories
[normal]. This leads to
[normal] inherent delays between tests, results and clinical interventions. Public health interventio
[normal]n may be further delayed by a 
[normal]time lag of 1-2 weeks
[normal],
[normal] associated with retrospective surveillance of laboratory tests.
[normal]&#xa0;
[normal]3.3[bold]&#xa0;&#xa0; 
[normal]There are national and international drivers to widen access to 
[normal]rapid 
[normal]tests at the point-of-care (
[normal]PoC
[normal]) but current tests (
[normal]e.g.
[normal] 
[normal]lateral flow
[normal] tests
[normal]) are typically not sensitive to early infections
[normal],
[normal] leading to missed opportunities for interventions.
[normal]6
[normal] 
[normal]&#xa0;
[normal]3.4[bold]&#xa0;&#xa0; 
[normal]Moreover while 
[normal]PoC
[normal] tests may speed diagnosis, 
[normal]this data must be captured. I
[normal]f capability to capture information for national and international surveillance is lost, so too will our ability to respond to future threats.
[normal] Therefore future rapid 
[normal]PoC
[normal] tests must be sensitive to early infections and combined with data linkage.
[normal] 
[normal]&#xa0;
[normal]4.0[bold]&#xa0;&#xa0; 
[normal]Is there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection? If not how could this be rectified?[bold]&#xa0;[bold]4.1[bold]&#xa0;&#xa0; 
[normal]In parallel with the development of new anti
[normal]microbials
[normal], t
[normal]here is a vital need for
[normal] [bold]new technologies to improve the early detection and diagnosis of infections, particularly in community settings. 
[normal]&#xa0;
[normal]4.2[bold]&#xa0;&#xa0; 
[normal]Research into new diagnostics has traditionally seen under-investment co
[normal]mpared to treatment and vaccine programmes
[normal] but there is a growing realisation that diagnostics are the gateway
[normal] to informing correct treatment
[normal] and prevention strategies
[normal]. Better diagnostics
[normal] will
[normal] 
[normal]curb
[normal] the inappropriate use of antibiotics, in turn preserving their effectiveness
[normal] for future generations
[normal].
[normal]&#xa0;[bold]4.3[bold]&#xa0;&#xa0; 
[normal]We welcome the 
[normal]Government’s 
[normal]recommendation to increase funding 
[normal]in this area
[normal] but we note that there is no reference 
[normal]in the report 
[normal]to EPSRC research.
[normal]1
[normal] 
[normal]There
[normal] is a crucial need for core underpinning engineering and physical sciences research to fuel a pipeline of innovative 21
[normal]st
[normal] century diagnostic and surveillance technologies to prevent the spread of AMR. 
[normal]We recommend prioritising research 
[normal]in 
[normal]two 
[normal]key areas: 
[normal](
[normal]i
[normal]) 
[normal]Web-tracking of infectious diseases across populations; (ii) Rapid Diagnostics with Data Linkage for Community Settings. 
[normal]&#xa0;[bold]4.4[bold]&#xa0;&#xa0; 
[normal] [bold]Web-tracking of infectious diseases across populations [bold]&#xa0;
[normal]4.41
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]The Government’s 
[normal]5 Year AMR Strategy 2013-18
[normal] 
[normal]focuses on 
[normal]improving 
[normal]traditional surveillance systems.
[normal]1
[normal] In addition, we recommend priorit
[normal]ising the use of web-
[normal]information
[normal] 
[normal]and crowd sourcing 
[normal]to improve early detection capabilities
[normal]. 
[normal]&#xa0;
[normal]4.42
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]Every week millions of people use the internet to search for information about health and self-report symptoms of an illness, often before they visit a doctor. For example, symptoms such as “fever”
[normal], 
[normal]“cough” 
[normal]or “
[normal]diarrhoea
[normal]” 
[normal]are investigated using search engines (e.g. Google or Bing), and posted on social 
[normal]networking
[normal] and 
[normal]microblogging
[normal] sites (e.g. Twitter). Although not everyone who types in symptoms is actually ill, 
[normal]a pattern emerges from trends in the total number of 
[normal]anonymised
[normal] searches
[normal] and tweets
[normal].
[normal] 
[normal]&#xa0;
[normal]4.43
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]Up-to-date estimates of outbreaks based on web-information linked to current epidemiological information may enable doctors to better respond to AMR.
[normal] Web-information also has the advantage that it could potentially track infections across a much larger proportion of the population 
[normal]than current surveillance 
[normal]and might identify outbreaks even before people attend clinics. 
[normal]&#xa0;
[normal]4.44
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]The low cost of these methods is likely to be of particular benefit in resource-limited settings such as developing countries, where infectious diseases are an enormous problem. 
[normal]&#xa0;
[normal]4.45
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]Web information and crowd sourcing has been exploited for the identification of disease outbreaks, such as influenza, at an early stage. Similar tools could be applied to AMR, in combination with rapid diagnostics. 
[normal]Key e
[normal]xamples of these technologies 
[normal]include
[normal]:
[normal] 
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]4.46
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]M
[normal]ore
[normal] 
[normal]research
[normal] is needed to improve the evidence-base of these potentially highly
[normal] 
[normal]valuable technologies
[normal] and extend their use to AMR
[normal].
[normal] Future research
[normal] should target tools to improve their accuracy
[normal], geographical granularity and
[normal] evaluate
[normal] of their cost-effectiveness
[normal]. 
[normal]&#xa0;
[normal]4.47
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]We would like to highlight o
[normal]ne of the key challenges facing the academic community in this area is restricted access to data, such as queries and tweets, held by private companies. New public-private partnerships, policy changes
[normal], 
[normal]governance frameworks are urgently required to responsibly develop this powerful resource for AMR, balancing the privacy of individuals with the benefits of research for the public good; 
[normal]&#xa0;
[normal]4.48
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]Data linkage to current surveillance systems will 
[normal]also 
[normal]be crucial. 
[normal]&#xa0;
[normal]4.49
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]Global coordination and action is urgently required since infectious diseases know no borders. More strategic alignment and investment is needed to support cros
[normal]s border activities and 
[normal]global networks of excellence. 
[normal]In particular, international web surveillance efforts could be significantly strengthened by a shared open-source software platform that provides the core software platform for national programs and allows national programs to focus on unique requirements, e.g. language.
[normal]&#xa0;
[normal]&#xa0;
[normal]4.5[bold]&#xa0;&#xa0; 
[normal]R[bold]apid Diagnostics with Data Linkage for [bold]C[bold]ommunity Settings[bold]:
[normal]&#xa0;
[normal]4.51
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]R
[normal]apid and accurate identification 
[normal]of the underlying agents using diagnostic tests is essential if we are to stop outbreaks with the correct control measures, for instance, containment, confinement, antimicrobials or vaccines. This is particularly true fo
[normal]r emerging resistance
[normal], where we find ourselves in a race to develop new controls as the disease spreads. 
[normal]&#xa0;
[normal]4.52
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]However 
[normal]current gold standard tests are laboratory-based and 
[normal]the inherent delays associated with 
[normal]sending sample off
[normal], 
[normal]obtaining 
[normal]test 
[normal]results and follow up appointments leads to delays in treatment and prevention strategies
[normal]. 
[normal]&#xa0;
[normal]4.53
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]The 
[normal]Government’s 5 Year AMR Strategy 2013-18,
[normal] highlights the urgent need for the deployment of 
[normal]PoC
[normal] diagnostics in community settings to speed diagnosis. However, robust, rapid, high-performance 
[normal]PoC
[normal] technologies 
[normal]must 
[normal]first 
[normal]be developed
[normal] to ensure this capability
[normal]. 
[normal]This will 
[normal]require significant 
[normal]future 
[normal]research into
[normal], for example,
[normal] new biomarkers
[normal] which reduce the need for complex sample preparation steps
[normal],
[normal] 
[normal]genomics, 
[normal]temperature-stable capture coatings, 
[normal]micro and 
[normal]nano
[normal]-
[normal]sensor systems
[normal] with on-chip sample handling capabilities
[normal], low power microelectronics
[normal], 
[normal]big data analytics
[normal] and data visualisation tools
[normal].
[normal] 
[normal]8-14
[normal] 
[normal]&#xa0;
[normal]4.54
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]Increased availability of cost effective and easily deployable testing allows timely, more appropr
[normal]iate, and less costly treatment.
[normal] 
[normal]I
[normal]t helps to rule out more expensive treatment and overtreatment, reduces 
[normal]the
[normal] cost of treatment complications, and potentially reduces the length of stay in hospital. 
[normal]Moving 
[normal]early diagnosis 
[normal]in
[normal]to the community – particularly in settings such as residential homes, provides the opportunity for significant reductions in morbidity and mortality.
[normal]&#xa0;
[normal]4.55
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]A
[normal]s testing becomes more widespread in a variety of non-hospital settings, 
[normal]it 
[normal]will become 
[normal]vital to
[normal] 
[normal]ensure information is 
[normal]capture
[normal]d
[normal] for 
[normal]disease 
[normal]surveillance. Rapid diagnostic tests with data linkage, such 
[normal]as
[normal] 
[normal]smartphone
[normal]-connected tests, offer huge potential for rapid, real-time, geographically tagged diagnosis. This evidence can be combined with 
[normal]web-tracking efforts to map
[normal] outbreaks at local, national and international levels to support
[normal] early
[normal] public health interventions. 
[normal]&#xa0;
[normal]4.56
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]T
[normal]he enormous rise in mobile phones and internet usage in 
[normal]developed and 
[normal]developing countries
[normal] 
[normal]presents 
[normal]an 
[normal]exciting 
[normal]opportunity
[normal] to 
[normal]dramatically 
[normal]widen access to 
[normal]“smart 
[normal]diagnostics 
[normal]tests” to
[normal] 
[normal]uncover and manage infection worldwide 
[normal]- 
[normal]for the common good. 
[normal]In 2013 the International Telecommunications Union estimates that there 
[normal]are 
[normal]6.8 billion mobile subscriptions 
[normal]with
[normal] rapid expansion in develop
[normal]ing countries.
[normal]1
[normal]4
[normal] Widening access to tests in community settings will empower patients to gain faster access to treatment, reduce the inappropriate use of antibiotics and protect the wider public.
[normal]&#xa0;
[normal]4.57
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]The rise in mobile health technologies is linked to a much larger trend in patients taking on much more interest and responsibility in their own health. For example, handheld glucose monitoring 
[normal]devices
[normal] 
[normal]with data linkage to doctors 
[normal]are the standard of 
[normal]care for patients with diabetes.
[normal] 
[normal]Mobile tests 
[normal]for AMR 
[normal]could also facilitate two-way interfaces, providing patients with advice on treatment (e.g. encouraging compliance to antibiotic treatment programmes) and relaying public information in the event of a serious outbreak. 
[normal]&#xa0;
[normal]4.58
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]However t
[normal]here 
[normal]remain
[normal] major 
[normal]scientific and 
[normal]technological challenges associated with the development of robust, high-performance tests for community settings. 
[normal]We see a need for
[normal] 
[normal]major programmes of basic research 
[normal]at the interface between physical sciences, engineering, life sciences and medicine, to 
[normal]support technology translation, 
[normal]improve 
[normal]regulatory guidance
[normal] 
[normal]and the heal
[normal]th economic evaluation of 
[normal]new mobile health technologie
[normal]s
[normal]. 
[normal]&#xa0;
[normal]4.59
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]We 
[normal]also 
[normal]recommend creating 
[normal]AMR Fellowships, 
[normal]Grand Challenge 
[normal]research 
[normal]programmes
[normal], 
[normal]Centres for Doctoral Training
[normal] and Global networks of excellence
[normal] in AMR
[normal]. Cre
[normal]ating the tools, skill-sets, 
[normal]trained 
[normal]personnel
[normal] 
[normal]and future leaders in AMR 
[normal]will ensure that the NHS
[normal] is best placed to take advantage of emerging technologies to tackle AMR, and will also provide commercial opportunities for British industry.
[normal]5.0[bold]&#xa0;&#xa0; 
[normal]References[bold]&#xa0;
[normal] 483 
[normal]Year published:
[normal](2013)
[normal];
[normal]&#xa0;[bold]&#xa0;[bold]6.0[bold] 
[normal]Declaration of Interests: [bold]We are a new EPSRC Interdisciplinary Research Collaboration which aims to develop an Early Warning Sensing System for Infectious Diseases. 
[normal]For more information 
[normal]please contact the IRC 
[normal]Director, 
[normal]Professor Rachel McKendry 
[normal](
[normal]r.a.mckendry@ucl.ac.uk
[normal]) 
[normal]and the Strategic Operations Director, Dr Tania 
[normal]Saxl
[normal] 
[normal](t.saxl@ucl.ac.uk
[normal]).
[normal] 
[normal]2
[normal]&#xa0;
[normal]